REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Representaciones Farmaceuticas Galex S.A.S. (Colombia)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Representaciones Farmaceuticas Galex S.A.S. Profile Updated: September 11, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Spanish Download a sample report

Representaciones Farmaceuticas Galex S.A.S. is an enterprise located in Colombia, with the main office in Medellin. The company operates in the Drugs and Druggists' Sundries Merchant Wholesalers industry. It was incorporated on January 13, 2014. Representaciones Farmaceuticas Galex S.A.S. currently employs 8 (2025) people. There was a net sales revenue drop of 41.18% reported in Representaciones Farmaceuticas Galex S.A.S.’s latest financial highlights for 2024. During that time, Representaciones Farmaceuticas Galex S.A.S.’s total assets decreased by 4.59%. The net profit margin of Representaciones Farmaceuticas Galex S.A.S. increased by 2.87% in 2024.

Headquarters
Calle 33 42 B 06 Oficina 1006 y 1206
Medellin; Antioquia;

Contact Details: Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.

Basic Information
Total Employees:
Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.
Financial Auditors:
Purchase the Representaciones Farmaceuticas Galex S.A.S. report to view the information.
Incorporation Date:
January 13, 2014
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Representaciones Farmaceuticas Galex S.A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-41.18%▼
Total operating revenue
-41.18%▼
Operating profit (EBIT)
27.86%▲
Net Profit (Loss) for the Period
27.86%▲
Total Assets
-4.59%▼
Total Equity
-11.9%▼
Operating Profit Margin (ROS)
2.87%▲
Net Profit Margin
2.87%▲
Return on Equity (ROE)
5.58%▲
Quick Ratio
-0.27%▼

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo